StockData
AgomAb Therapeutics NV logo

AgomAb Therapeutics NV (AGMB) stock

AGMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 23, 2026Score 2/30
$5.62−0.20 (-3.44%)

Close on Nov 19, 2026Market cap $140.50KP/E –Yield –

AgomAb Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 1M, up 0.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M0.0%
FY2024Dec 31, 20241M0.0%
FY2023Dec 31, 20231M–

More AgomAb Therapeutics figures

See a number that looks wrong?